KO - The Coca-Cola Company

NYSE - NYSE Delayed Price. Currency in USD
49.20
-0.38 (-0.77%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close49.58
Open49.27
Bid49.07 x 1200
Ask49.36 x 2200
Day's Range49.17 - 49.55
52 Week Range41.93 - 50.84
Volume11,257,015
Avg. Volume14,659,290
Market Cap209.893B
Beta (3Y Monthly)0.30
PE Ratio (TTM)31.28
EPS (TTM)1.57
Earnings DateJul 23, 2019 - Jul 29, 2019
Forward Dividend & Yield1.60 (3.26%)
Ex-Dividend Date2019-06-13
1y Target Est51.95
Trade prices are not sourced from all markets
  • 3 Brand-Name Food and Beverage Companies That Want In on the Marijuana Craze
    Motley Fool2 days ago

    3 Brand-Name Food and Beverage Companies That Want In on the Marijuana Craze

    Edibles and infused beverages have these well-known snack and beverage businesses seeing green.

  • 5 Great Blue-Chip Stocks to Buy Today
    InvestorPlace3 days ago

    5 Great Blue-Chip Stocks to Buy Today

    If you're like me, the current bout of trade-induced volatility isn't sitting too right. And while swings and bear markets are a part of investing, the kind of big plunges we've recently seen does make for some sleepless nights. Which is why the stocks to buy today could be America's blue-chip stocks.Blue-chip stocks don't necessarily have a formal definition, but they are generally stable and well-established companies. Blue-chip stocks are typically household names with billions in revenues and steady rising profit profiles. Often, they share the wealth with their investors via rich dividend and buyback programs. The best part is that investors can count on blue-chip stocks to help them get through periods of malaise and bear markets as they tend to be less volatile than let's say, smaller growth stocks.To that end, with the markets starting to feel a bit shaky, blue chip stocks could be the best way to position your portfolio in the upcoming months.InvestorPlace - Stock Market News, Stock Advice & Trading Tips * 6 Chinese Stocks That Could Pop On a Trade Deal But which blue-chip stocks make sense to buy today? Here are five that could help you get through the next few months and an upcoming bear market. Cisco Systems (CSCO)Source: Shutterstock The technology sector is often seen as a growth element for a portfolio. However, the sector does feature plenty of blue-chip stocks that produce mountains of cash flows, steady dividends, and rising profits. Case in point, former dot-com darling Cisco Systems (NASDAQ:CSCO).After building the internet and networking with its focus on switching gear and routers, CSCO made the smart pivot into services and reoccurring revenues. It basically created the model that many tech firms have copied. And in doing that, Cisco has become a cash generation machine. Last quarter alone, the firm managed to produce more than $3.5 billion in free cash flows.The best part is that CSCO continues to share that cash with investors. The firm recently raised its dividend by 6% and added another $15 billion to its authorized buyback program.And yet, more could be in store for Cisco. The firm continues to add new capabilities to its services platform and recently unveiled new conversational A.I. to its interfaces. Adding in continued data center demand as well as the pending 5G upgrades and Cisco continues to look great.For investors looking for a strong tech sector blue-chip stock, Cisco has to be your top pick. Merck (MRK)Source: Shutterstock The steadfastness of the healthcare sector makes it a prime place to find plenty of blue-chip stocks. And one of the best could be pharmaceutical giant Merck (NYSE:MRK).For starters, MRK features a wide portfolio of current and former blockbuster drugs, vaccines and other therapies. This huge portfolio continues to drive profits and cash flows at the giant. But MRK isn't resting on its laurels. A few years ago, Merck made the shift into newer biotech and advanced cancer-fighting medications. That has turned out to be the right move.MRK's Keytruda has quickly become the go-to medicine for a variety of lung cancers and sales going through the roof. Last quarter alone, the blue-chip stock realized more than $2.2 billion in Keytruda sales alone. That double-digit growth has allowed Merck to up its total forecast and guidance for the entire year. The growth of Keytruda could continue. Merck has begun several trials looking to use the drug in other indications. This could provide even more cash flowing Merck's way. Combining the growth of its cancer portfolio with the rest of its steady drug options, and Merck is looking like a great buy for the long haul. * 5 Service Stocks That Can Win the Trade War -- According to Goldman Sachs In the end, MRK's 2.85% yield and continued growth make it a powerful blue-chip stock for any investor. American Express Company (AXP)Source: Shutterstock One of Warren Buffett's favorite blue-chip stocks happens to be American Express (NYSE:AXP). And the Oracle of Omaha isn't wrong in owning it. The financial powerhouse has continued to thrive in the rising economy and has a lot to offer investors.AXP is kind of a weird bird. Like rivals, Visa (NYSE:V) and Mastercard (NYSE:MA) -- also two blue-chip stocks worth owning -- American Express operates a secured payment network and acts as a toll road when customers swipe their cards. Here, Amex scores a hefty fee. The firm's discount revenue rate was last quarter was 2.37%. Basically, for every $100 spent on its cards, $2.37 flowed back to AXP. All in all, last quarter, American Express pulled in more than $6.2 billion in revenue from these operations.Secondly, unlike V and MA, American Express is an issuer of its cards. Because of this, it's able to score hefty membership fees, interest and creates a leverage effect for its profits. Moreover, Amex's entire M.O. is about rewards and its partners pay the credit issuer plenty of fees to get their products/offers onto AXP's platform.The best part is that AXP tends to focus on the higher end of the credit spectrum. This removes many of the uncertainty and issues with offering loans and reduces default rates.All of this has made American Express a powerhouse in the financial sector. Best Buy Chip Stocks: Genuine Parts Company (GPC)Source: Shutterstock Sixty-three years. That's an amazing streak for any firm to consistently raise their dividend. But for blue-chip stock Genuine Parts Company (NYSE:GPC), it's just par for the course. The secret lies with the firms massive and irreplaceable moat.There's a good chance that you've never walked into one of GPC's locations, but your mechanic has. Under the NAPA banner, the firm operates one of the largest networks of auto parts and industrial distribution locations in the nation. Those 9,250 locations are located pretty much everywhere and that's key. Auto parts are generally a "need it now" sort of item and are pretty much immune from the whims of online sales.Because of this huge network, GPC and NAPA are pretty much the only game in town when it comes to getting parts to body shops, mechanics and service centers. This has been beyond good for GPC's bottom line over the years. In its 90-year history, sales have increased in 85 of those years. This streak was continued last year as GPC recorded more than $18.7 billion in revenues. Analysts predict that revenues will jump by about 4% this year. Naturally, those sales have turned into profits and a long streak of dividend increase for investors. * The 3 Best Marijuana Stocks to Buy Right Now This consistency has made GPC one of the best blue-chip stocks to own for the long haul. Coca-Cola (KO)Source: Chris Nielsen via FlickrWhen it comes to blue chip stocks, Coca-Cola (NYSE:KO) could be the bluest. Its brand is worldwide and is enjoyed millions of times daily. This has allowed KO to pay a constantly rising dividend for the last 55 years and provide plenty of ballast to a portfolio in markets just like today.And there is still growth to be had.Coke has moved into new beverage categories as tastes have changed. Sparkling water, juices, teas, and other healthy drinks are now on a menu at the firm. And these items continue to grow -- with revenues for these products now accounting for about half of KO's total pie. Meanwhile, KO has improved margins via new packaging designs and sizes. Adding in some tech -- such as its Arctic Coolers and Freestyle machines -- and Coke seems to be winning the beverage wars.The proof is in the pudding. Continued product mix development has resulted in a big 5% jump in revenues last quarter. Likewise, earnings saw a big surge and KO has managed to produce roughly $6.28 billion in free cash flow over the last 12 months.Yes, KO is boring. But that's what exactly what investors should be looking for in a blue-chip stock. Consistency, with a touch of growth. If that doesn't describe Coca-Cola, then I don't know what does.Disclosure: At the time of writing, Aaron Levitt did not have a position in any stock mentioned. More From InvestorPlace * 4 Top American Penny Pot Stocks (Buy Before June 21) * 7 Stocks to Buy that Lost 10% Last Week * Top 7 Dow Jones Stocks of 2019 -- So Far * 5 Service Stocks That Can Win the Trade War -- According to Goldman Sachs Compare Brokers The post 5 Great Blue-Chip Stocks to Buy Today appeared first on InvestorPlace.

  • The Bullish Thesis for Tilray Stock Is Still Alive and Well
    InvestorPlace3 days ago

    The Bullish Thesis for Tilray Stock Is Still Alive and Well

    Every so often, Wall Street experiences a craze that is fascinating like Bitcoin in 2017. But now it's the cannabis stocks and Tilray (NASDAQ:TLRY) has been a wild one to watch. It went public last year and within two months it had rallied 1,000%. 2019 has not been kind to TLRY stock as it's down 32% year-to-date, yet it is still up 110% since its inception. Compare that to the S&P 500, which is barely up 2% in a year.Source: Shutterstock Today's write up is to encourage those who like the stock to hold it and to also discourage those who want to short it. For full disclosure, I am not long Tilray nor am I an uber fan or a perma-bull of it.While the IPO was orderly, the period that followed was bonkers. In September it spiked to its $300 all-time high from $93 in three days. Clearly, it was a massive short squeeze where buying begot buying until the equilibrium was restored.InvestorPlace - Stock Market News, Stock Advice & Trading TipsUnfortunately for the Tilray stock bulls that was the high mark and it has traded horrendously since then. It is now below $50 and it can't sustain a rally. It's not so much that the fundamentals have deteriorated greatly. It is simply that the stock trade broke from the massive artificial rally. It takes time to restore the natural price action.TLRY still has not grabbed the attention of major corporations. Canopy Growth (NYSE:CGC) and Cronos (NASDAQ:CRON) got billions from Constellation Brands (NYSE:STZ) and Altria (NYSE:MO). Tilray is still going at it alone and it's struggling. It will need better alliances or it risks falling behind.Before you send me hate mail on this, I am not calling TLRY stock dead. Cannabis stocks are a special breed in this early stage. They are trying to establish the industry on Main Street and they may not be able to always impress Wall Street in the short term. There will be ups and downs but the bullish thesis is too diverse in scope to call it dead now. * 10 Baby Boomer Stocks to Buy So what's a fair value for TLRY stock? There is none because at this point they all carry massive market capitalization but with a tiny fraction of it in sales. TLRY's cap is $6 billion and it recently reported $23 million in sales.To that, management reported a big top line beat and 195% growth year over year. The stock spiked 6% on the headline and it is holding the zone decently given the overall stock market jitters. More importantly, its deliveries doubled year-over-year and that is the focus of many experts. They can't grow into their potential if they cannot deliver it as well as improve their margins along the way.The cannabis industry is still trying to adjust to its new legal status. This is a trend that is spotty for now but will grow its ubiquity with time. The U.S. market is an important one and many states will soon follow the ones that have already legalized it. But on the federal level, it may not be that easy. Luckily there are dozens of other countries for TLRY to potentially serve. Bottom Line on TLRY StockThe hoopla around cannabis stocks like Tilray is that they will disrupt so many huge markets that their upside potential should also be massive. The recreational use is what first comes to mind to most people but there are so many more like medicinal applications, potables and edibles. Maybe one day pot-based drinks will replace some of the soda, wine and beer consumption. * Top 7 Dow Jones Stocks of 2019 -- So Far Skeptics would call it a craze. Maybe, but unlike bitcoin where the concept escapes 99% of all people, everyone knows what cannabis is and is immediately interested in learning more about it. The allure of it is undeniable as I see evidence of the interest everywhere I go.So the bottom line is that although the experts can dismiss Tilray based on valuation and its distance from its all-time high, they would be making a mistake. Because as big as the potential of this multi-headed future area of business is, it will be impossible to quantify here let alone judge it right. Either avoid it altogether or plug your nose and buy the stock for the long term.We saw the skeptics lose fortunes trying to short Amazon (NASDAQ:NFLX) and Netflix (NASDAQ:NFLX). Netflix still gets a pass on profitability because of its global expansion potential as should most cannabis stocks … including TLRY stock.Nicolas Chahine is the managing director of SellSpreads.com. As of this writing, he did not hold a position in any of the aforementioned securities. You can follow him as @racernic on Twitter and Stocktwits. More From InvestorPlace * 4 Top American Penny Pot Stocks (Buy Before June 21) * 7 Stocks to Buy that Lost 10% Last Week * Top 7 Dow Jones Stocks of 2019 -- So Far * 5 Service Stocks That Can Win the Trade War -- According to Goldman Sachs Compare Brokers The post The Bullish Thesis for Tilray Stock Is Still Alive and Well appeared first on InvestorPlace.

  • Business Wire5 days ago

    The Coca-Cola Company to Present at Deutsche Bank Global Consumer Conference

    The Coca-Cola Company today announced that Chief Financial Officer John Murphy will present on June 12 at 10:30 a.m. CET at the Deutsche Bank Global Consumer Conference in Paris.

  • For Aurora Stock, The Bullish Bet Is Still On
    InvestorPlace5 days ago

    For Aurora Stock, The Bullish Bet Is Still On

    On Monday, when the markets were falling off a cliff from fears of the tariff war with China, the headlines were about Aurora Cannabis (NYSE:ACB) tumbling ahead of earnings. But on Tuesday, the stock closed up 4.5% into the earnings event. This morning ACB is down 1.2% on the earnings headline, though it dipped lower earlier. Clearly it's an emotional stock, and investors have strong opinions on either side of the ledger.Overnight, ACB reported earnings and Wall Street did not like what they saw. This was the opposite reaction to Tilray's (NASDAQ:TLRY) earnings last night, which was up around 3.5% before falling back to a -3%.The sellers stepped into ACB because they missed on both the top and bottom lines. Earnings were three times worse than forecast but that's not the big problem as this is a growth stock and profits are not too big a concern for now. But they also missed on the revenue forecast. Luckily their sales were four time bigger than last year, they just failed to deliver what investors were expecting.InvestorPlace - Stock Market News, Stock Advice & Trading TipsThe bottom line is that traders wanted pizzazz and ACB did not deliver it this quarter. This doesn't change the long term bullish thesis for it. What Now for ACB Stock?While 2019 has been good for stocks as the S&P 500 is up 13%, the year has been great for cannabis stocks. ACB came into the earnings up 36% year to date, for example, and it's not even the star of the sector. Cronos (NASDAQ:CRON) and TLRY are up more than double that. Clearly there is froth, but in this case it's not a reason to avoid the stocks. The thesis to own them is not value.Fundamentally the metrics for cannabis stocks do not make sense. ACB sells at a 150 price-to-sales and carries a market capitalization of $8 billion for tiny sales sales. While this sounds like lunacy, this is a budding industry so we don't have yet the right metrics to properly judge the value. * 10 Retirement Stocks That Won't Wilt in a Bear Market For now, production and deliveries are important to the experts and Aurora kept their 25,000 kilos fourth quarter goal. Think of it as an asset that is in demand and that they can't source enough of it to satisfy the demand. And here the demand is insanely strong.I have rarely seen such excitement over a commodity like cannabis. It is a strong draw regardless of the format. There is tremendous interest in the products but also for the cannabis stocks too. The chat rooms are packed if they are discussing pot stocks. Yes, it's not all about the pot but it's the original draw.Since the cannabis companies stepped on the global platform, the experts started to speculate on applications for the stuff. We already knew about the edibles, but then the potables quickly grabbed the attention of the large corporations that sell sodas and booze. The chatter was that drinkable pot was going to disrupt the recreational beverage markets.The mainstream mega-caps quickly saw the threat, and they, too, are trying to turn it into an opportunity. For example Constellation Brands (NYSE:STZ) gave $4.5 billion to TLRY and Altria (NYSE:MO) invested similarly in ACB.These capital investment headlines are infectious among corporations and the retail investors. This reminds me of the bitcoin mania of 2017. Hopefully the cannabis sector has more runway than bitcoin. There are similarities, but cannabis has more buy-in from a much larger section of the population. Everyone knows what cannabis is but few can explain what's a crypto-coin.So fundamental metrics aside, you own this stock because you believe that the industry has tremendous growth ahead. The concept behind that is that cannabis companies will disrupt several industries, including the medical community, so the sky is the limit for now.That's why the traditional ways to measure valuation do not apply here. The best recent example of this is Netflix (NASDAQ:NFLX). Investors gave it a pass on valuation for the longest time because of the global growth potential. So as long as it had the opportunity to expand into a massive market they didn't care about how expensive NFLX was.Even though management said that they will be EBITDA positive soon, ACB stock here is in an industry that has the same profitability pass. The potential market for cannabis seems endless, so it's only logical to expect that early movers like Aurora Cannabis will be huge beneficiaries and that it's only a matter of time.So I don't judge and I simply plug my nose and own it. They do have tremendous regulatory headwinds but those will also eventually be a huge part of the incremental opportunities.Technically, there are a few levels to note for the short term. The $8 area has been pivotal for almost two years. These tend to be support on the way down so from here the bulls should have solid footing to target new highs. And in fact, this week's selloff was hard and tested the support and $8 held on the button.Conversely, if the bears eventually manage to break below $8 they could invite momentum sellers to retest $6.80 where they next major level of support lies. This is not a forecast but a scenario unfolding. There are other micro levels but if the thesis is to own ACB stock for the long term then it's futile to waste time dissecting the micro time frames.Nicolas Chahine is the managing director of SellSpreads.com. As of this writing, he did not hold a position in any of the aforementioned securities. You can follow him as @racernic on Twitter and Stocktwits. More From InvestorPlace * 4 Top American Penny Pot Stocks (Buy Before June 21) * 10 Retirement Stocks That Won't Wilt in a Bear Market * 5 Consumer Stocks Ready to Push Higher * 3 of the Best ETFs to Buy for a Play on Gold Stocks Compare Brokers The post For Aurora Stock, The Bullish Bet Is Still On appeared first on InvestorPlace.

  • After Hours: Tilray Tops, Agilent Whiffs, Coca-Cola Gets Some Fizz
    Motley Fool5 days ago

    After Hours: Tilray Tops, Agilent Whiffs, Coca-Cola Gets Some Fizz

    Quarterly results are having a post-market effect on two stocks, while a big bank's recommendation change bolsters a familiar name.

  • Will Coca-Cola Deliver Better Results in 2019?
    Market Realist6 days ago

    Will Coca-Cola Deliver Better Results in 2019?

    Coca-Cola Stock Up after Morgan Stanley Ratings Upgrade(Continued from Prior Part)Company expectations Coca-Cola (KO) delivered strong results for the first quarter of fiscal 2019. Coca-Cola’s first-quarter revenue rose 5.2% on a year-over-year

  • Coca-Cola Stock Up after Morgan Stanley Ratings Upgrade
    Market Realist6 days ago

    Coca-Cola Stock Up after Morgan Stanley Ratings Upgrade

    Coca-Cola Stock Up after Morgan Stanley Ratings UpgradeRatings upgradeCoca-Cola (KO) stock was up 1.8% as of 2:19 PM today after Morgan Stanley raised its rating for the soda giant from “equal weight” to “overweight.” Morgan Stanley believes

  • 5 Consumer Stocks Ready to Push Higher
    InvestorPlace6 days ago

    5 Consumer Stocks Ready to Push Higher

    Thanks to another well-timed tweet by President Donald Trump, U.S. equities are bouncing back on Tuesday on fresh hope for a U.S.-China trade deal. Also helping was Trump's disputing of a New York Times report that the Pentagon is reviewing a military plan for Iran that involves sending 120,000 troops to the Middle East.This stands in stark contrast to the fears in play on Monday, with China vowing retaliatory measures including curtailing imports of Boeing (NYSE:BA) aircraft and the dumping of U.S. Treasury holdings. * 6 Trade War Stocks With a Lot of Risk The move was enough to push the Dow Jones Industrial Average back above its 200-day moving average and is focusing buyer attention on the handful of stocks that have largely ignored the month-long bout of volatility. Here are five worth a look:InvestorPlace - Stock Market News, Stock Advice & Trading Tips Consumer Stocks :Procter & Gamble (PG)Procter & Gamble (NYSE:PG) shares have shaken off the broad market pressure to keep marching higher, inching towards a new record high as it keeps riding support near its 50-day moving average. Shares were also barely affected by the volatility seen late last summer as well, continuing an uptrend that started in April 2018 that has seen shares gain more than 50%.The company is scheduled to next report results on July 30 before the bell. Analysts are looking for earnings of $1.05 per share on revenues of $16.9 billion. When the company last reported on April 23, earnings of $1.06 per share beat estimates by two cents on a 1.1% rise in revenues. Coca-Cola (KO)Shares of Coca-Cola (NYSE:KO) are rising up to challenge resistance from double-top highs near the $50-a-share threshold. Zooming out, the stock has been in a steady if somewhat choppy uptrend since the 2009 bear market low -- the very definition of what you would expect from a well-run consumer staples company. * 7 Dividend Stocks to Buy as the Trade War Reignites Results will next be reported on July 25 before the bell. Analysts are looking for earnings of 62 cents per share on revenues of $9.4 billion. When the company last reported on April 23, earnings of 48 cents per share beat estimates by two cents on a 5.2% rise in revenues. Colgate-Palmolive (CL)Shares of Colgate-Palmolive (NYSE:CL) are pushing higher to challenge highs the stock last set in early 2018. This continues a sideways channel that has been in place since the middle of 2016. Shares were recently upgraded to "buy" by analysts at Zacks, who are looking for a $80-a-share price target.The company will next report results on July 26 before the bell. Analysts are looking for earnings of 72 cents per share on revenues of $3.9 billion. When the company last reported on April 26, earnings of 67 cents per share beat estimates by a penny on a 2.9% drop in revenues. Management reaffirmed its relatively bright 2019 outlook as well. General Mills (GIS)General Mills (NYSE:GIS) shares are continuing to attempt a breakout up and over three-month resistance near the $52-a-share level, setting up a run at its early 2018 highs near the $57-a-share level. Such a move would be worth a gain of nearly 10% from here. Shares have been trading at a discount to the average consumer packaged goods stock this year, making its relative price stability even more valuable in these volatile times. * 7 Cloud Stocks to Buy on Overcast Days The company is scheduled to next report results on June 26 before the bell. Analysts are looking for earnings of 76 cents per share on revenues of $4.3 billion. When the company last reported on March 20, earnings of 83 cents per share beat estimates by 14 cents on an 8.1% rise in revenues. GoPro (GPRO)GoPro (NASDAQ:GPRO) is something of an unusual pick for this list, on account of its position as a turnaround consumer electronics name. Shares have cratered since reaching a high in late 2015, losing some 95% of their value into the low set in December. Since then, shares have been scrambling higher and are pushing up and over their April high today.The company will next report results on August 1 after the close. Analysts are looking for earnings of four cents per share on revenues of $301 million. When the company last reported on May 9, a loss of seven cents per share beat estimates by two cents on a 20.1% rise in revenues.As of this writing, William Roth did not hold a position in any of the aforementioned securities. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 6 Trade War Stocks With a Lot of Risk * 7 Bond ETFs to Buy * 10 Stocks That Could Squeeze Short Sellers, Including CGC Compare Brokers The post 5 Consumer Stocks Ready to Push Higher appeared first on InvestorPlace.

  • Reuters6 days ago

    US STOCKS-Tech stocks power Wall Street's recovery from trade-led selloff

    U.S. stock indexes rebounded on Tuesday from one of their worst selloffs in 2019, as investors saw value in technology stocks that took a hit on Monday from heightened trade tensions between the United States and China. While China said it will the keep talks going, U.S. President Donald Trump said he would talk with his Chinese counterpart at a G20 Summit in late June.

  • CNBC6 days ago

    Stocks making the biggest moves midday: Coca-Cola, Disney, Deckers Outdoor & more

    These are the stocks posting the largest moves midday.

  • Reuters6 days ago

    Carrefour and TerraCycle launch 'Loop' test in Paris to tackle waste

    French retailer Carrefour and U.S. waste recycling company TerraCycle launched on Tuesday the test for their 'Loop' initiative which they hope will tackle the problems of plastic waste threatening to destroy the environment. The 'Loop' online platform will allow shoppers in the Paris area to buy orange juice, powder detergent or shampoo in reusable containers that do not result in waste. Users put down a refundable deposit via the Loop website when ordering products, which are delivered in reusable glass and metal bottles, and shipped in a tote bag to shoppers' doors.

  • Reuters6 days ago

    US STOCKS-Tech stocks help Wall St rebound from trade-driven rout

    U.S. stocks climbed on Tuesday, as investors picked up beaten-down technology and industrial stocks following optimistic comments from Washington and Beijing that tempered concerns about a further escalation in the trade war. Technology shares rose 1.56%, the most among major S&P sectors, lifted by gains in Microsoft Corp, Visa Inc and chipmakers. Wall Street witnessed one of its worst selloffs this year in the previous session, with the S&P and the Dow recording their largest percentage drops since Jan. 3, after China announced retaliatory tariffs on U.S. goods.

  • Barrons.com6 days ago

    Time to Buy Coca-Cola Stock? Morgan Stanley Thinks So

    Morgan Stanley says Coke has among the best sales-growth potential of any consumer-staples company, although the market has yet to acknowledge this.

  • Benzinga6 days ago

    Morgan Stanley Upgrades Coca-Cola, Sees More Growth Ahead

    Coca-Cola Co (NYSE: KO ) has reacted well to changes in the beverage marketplace and upped its pricing power just as emerging market trends appear to be rebounding, Morgan Stanley analysts said Tuesday. ...

  • Barrons.com6 days ago

    Beyond Meat and Impossible Foods Could Be the Coke and Pepsi of Alternative Meat

    Competition is heating up in the alternative-meat category. Beyond Meat competitor Impossible Foods just raised $300 million.

  • Reuters6 days ago

    US STOCKS-Wall Street attempts rebound, with help from tech stocks

    U.S. stocks edged higher on Tuesday, as investors picked up beaten-down technology and industrial stocks following optimistic comments from Washington and Beijing that tempered concerns about a further escalation in the trade war. The S&P 500 and the Dow recorded their largest percentage drops since Jan. 3 on Monday in one of Wall Street's worst selloffs this year after China hit back with tariffs on $60 billion worth U.S. goods. U.S. President Donald Trump said on Monday he would talk to Chinese President Xi Jinping at a G20 Summit in late June and China said both sides have agreed to keep the talks going, helping inject some calm into the markets.

  • TheStreet.com6 days ago

    Coca-Cola Nudges Higher After Morgan Stanley Upgrades to Overweight

    Shares of Coca-Cola were rising Tuesday in premarket trading after analysts at Morgan Stanley upgraded the consumer staples giant to overweight from equal weight. The stock was rising 2.36% to $49.18 a share.

  • MarketWatch6 days ago

    Coca-Cola's stock climbs to pace Dow gainers after Morgan Stanley turns bullish

    Shares of Coca-Cola Co. climbed 2.1% in morning trade, enough to pace the Dow Jones Industrial Average's gainers, after Morgan Stanley upgraded the beverage giant, citing valuation. Analyst Dara Mohsenian raised his rating to overweight from equal weight, and boosted his price target to $55 from $52, saying he believes the company has morphed into a structurally higher sales growth company relative to its consumer packaged goods (CPG) peers. Mohsenian said that "surprisingly, and despite clear historical proof," that this is not being recognized in valuation, at what he sees as an "unfair discount to peers." That has provided a "compelling buying opportunity" for investors, Mohsenian said. The stock has gained 3.6% year to date, while the SPDR Consumer Staples Select Sector ETF has rallied 12.5% and the Dow Jones Industrial Average has advanced 9.1%.

  • Reuters6 days ago

    US STOCKS-Wall Street poised for gains after Monday's heavy selloff

    Wall Street witnessed one of its worst selloffs this year in the previous session, with the S&P 500 and the Dow recording their largest percentage drops since Jan. 3 and the tech-heavy Nasdaq logging its worst day in 2019 as investors scoured for safety in low-risk assets. U.S. President Donald Trump said on Monday he would talk to Chinese President Xi Jinping at G20 Summit in late June, while China said both sides have agreed to keep the talks going, helping inject some calm into markets.

  • Reuters6 days ago

    US STOCKS-Futures steady after Monday's drastic selloff

    U.S. stock index futures indicated gains at the open on Tuesday, as optimistic comments from Washington and Beijing took the edge off market concerns about a further escalation in trade war. The S&P 500 and the Dow recorded their largest percentage drop since Jan.3 and the tech-heavy Nasdaq logged its worst day as investors scoured for safety in low-risk assets. U.S. President Donald Trump said on Monday he would talk to Chinese President Xi Jinping at G20 Summit in late June.

  • CNBC6 days ago

    Morgan Stanley upgrades Coca-Cola to overweight: 'Coke is now our top mega-cap staples pick'

    Coca-Cola shares traded higher following the bullish call from Morgan Stanley.

  • Investing.com6 days ago

    Stocks - Coca-Cola Gains in Premarket, Uber, Apple, Tesla Rebound

    Investing.com - Stocks in focus in premarket trade Tuesday:

  • Losing My Religion on Repurchases
    GuruFocus.com6 days ago

    Losing My Religion on Repurchases

    As Warren Buffett (Trades, Portfolio) recently noted, "When the price is right, there's no easier way to make money for your shareholders [than repurchases]". Warning! GuruFocus has detected 5 Warning Sign with KO.